Genetic Signatures Ltd

NEW
ASX:GSS (Australia)  
A$ 0.066 -0.0010 (-1.49%) Jul 21
At Loss
P/B:
0.33
Market Cap:
A$ 14.99M ($ 10.50M)
Enterprise V:
A$ -14.32M ($ -10.03M)
Volume:
23.65K
Avg Vol (2M):
677.28K
Trade In:
Volume:
23.65K
At Loss
Avg Vol (2M):
677.28K

Business Description

Description
Genetic Signatures Ltd is a specialist molecular diagnostics company, specializing in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are based in Australia, with sales and support teams in the UK, Germany, and the United States.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
53.44
Equity-to-Asset
0.9
Debt-to-Equity
0.01
Debt-to-EBITDA
-0.06
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-0.14
Distress
Grey
Safe
Beneish M-Score
-3.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
54.19
9-Day RSI
51.28
14-Day RSI
48.56
3-1 Month Momentum %
-56
6-1 Month Momentum %
-66.15
12-1 Month Momentum %
-84.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
8.99
Quick Ratio
7.2
Cash Ratio
6.25
Days Inventory
353.08
Days Sales Outstanding
67.92
Days Payable
123.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-15.7
Shareholder Yield %
2.87

Financials

ASX:GSS's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Genetic Signatures Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 16.082
EPS (TTM) (A$) -0.048
Beta 0.1871
3-Year Sharpe Ratio -1.09
3-Year Sortino Ratio -1.21
Volatility % 52.14
14-Day RSI 48.56
14-Day ATR (A$) 0.003836
20-Day SMA (A$) 0.0647
12-1 Month Momentum % -84.29
52-Week Range (A$) 0.057 - 0.43
Shares Outstanding (Mil) 227.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genetic Signatures Ltd Filings

Filing Date Document Date Form
No Filing Data

Genetic Signatures Ltd Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Genetic Signatures Ltd Frequently Asked Questions

What is Genetic Signatures Ltd(ASX:GSS)'s stock price today?
The current price of ASX:GSS is A$0.07. The 52 week high of ASX:GSS is A$0.43 and 52 week low is A$0.06.
When is next earnings date of Genetic Signatures Ltd(ASX:GSS)?
The next earnings date of Genetic Signatures Ltd(ASX:GSS) is .
Does Genetic Signatures Ltd(ASX:GSS) pay dividends? If so, how much?
Genetic Signatures Ltd(ASX:GSS) does not pay dividend.

Press Release

Subject Date
FDA Clearance For Gastrointestinal Parasite Detection Kit 2024-06-04
10/Page

Articles on Genetic Signatures Ltd

No articles.